Online citations, reference lists, and bibliographies.
← Back to Search

Enhanced Expression Levels Of IL-31 Correlate With IL-4 And IL-13 In Atopic And Allergic Contact Dermatitis.

M. Neis, B. Peters, A. Dreuw, J. Wenzel, T. Bieber, C. Mauch, T. Krieg, S. Stanzel, P. Heinrich, H. Merk, A. Bosio, J. Baron, H. Hermanns
Published 2006 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
BACKGROUND IL-31 is produced by activated T lymphocytes, preferentially by TH2 cells. Transgenic mice overexpressing IL-31 have a phenotype resembling allergic dermatitis in human subjects. OBJECTIVE We sought to evaluate the potential importance of IL-31 in the pathogenesis of human T cell-mediated skin diseases. METHODS We analyzed total RNA taken from 149 skin biopsy specimens from patients with atopic dermatitis (AD), allergic contact dermatitis (ACD), or psoriasis in comparison with specimens taken from patients with healthy skin (n = 13) by using quantitative real-time PCR for the expression of TH1/TH2 cytokines. RESULTS We found statistically increased mRNA levels of IL-31 in biopsy specimens taken from patients with AD, irrespective of the severity of the disease and serum IgE levels. Moreover, IL-31 mRNA levels were strongly increased in many biopsy specimens taken from patients with ACD. However, no increased transcription of IL-31 could be detected in biopsy specimens taken from psoriatic plaques. A comparison of mRNA levels of IL-31 with TH1 or TH2 cytokines demonstrates a correlation of the expression of IL-31 with IL-4 and IL-13 but not with IFN-gamma. No significant increase of IL-31 receptor mRNA could be detected in any disease, whereas the second receptor subunit of IL-31, the oncostatin M receptor, seems to be enhanced transcribed in patients with psoriasis. CONCLUSION IL-31 expression is not only increased in patients with AD but also in those with ACD, 2 pruritic skin disorders. In both types of eczema, expression of IL-31 is associated with the expression of the TH2 cytokines IL-4 and IL-13. CLINICAL IMPLICATIONS IL-31 might contribute not only to the development of AD but also to ACD-provoked skin inflammation.
This paper references
10.7326/0003-4819-71-1-229_2
Clinical aspects of immunology
P. Gell (1968)
Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.
D. Cher (1987)
The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones.
T. A. Fong (1989)
10.1016/0092-8674(90)90011-3
IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice
R. Tepper (1990)
10.1073/PNAS.87.5.1663
Amplified RNA synthesized from limited quantities of heterogeneous cDNA.
R. V. Van Gelder (1990)
10.1111/1523-1747.EP12494841
Th1 lymphokine production profiles of nickel-specific CD4+T-lymphocyte clones from nickel contact allergic and non-allergic individuals.
M. Kapsenberg (1992)
10.1172/JCI117408
Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.
Q. Hamid (1994)
10.1016/S0140-6736(94)90879-6
Lesional expression of interferon-γ in atopic eczema
M. Grewe (1994)
Interleukin-4 is a critical cytokine in contact sensitivity.
A. Salerno (1995)
10.1006/CIMM.1995.1196
TH2-type infiltrating T cells in nickel-induced contact dermatitis.
P. Probst (1995)
10.1084/JEM.181.5.1935
Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen
L. F. Santamaria Babi (1995)
10.1046/j.1365-2249.1996.845537.x
Role of IL‐4 in delayed type hypersensitivity
G. Asherson (1996)
10.1016/S0091-6749(96)70246-4
In vivo expression of IL-12 and IL-13 in atopic dermatitis.
Q. Hamid (1996)
10.1016/S0091-6749(96)80161-8
Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study.
T. Thepen (1996)
10.1093/INTIMM/9.3.461
Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice.
H. Matsuda (1997)
10.1084/JEM.185.2.329
Constitutive Expression of Interleukin (IL)-4 In Vivo Causes Autoimmune-type Disorders in Mice
K. Erb (1997)
10.1042/BJ3340297
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
P. Heinrich (1998)
10.1016/S0091-6749(99)70052-7
Itching and the atopic skin.
C. Koblenzer (1999)
10.1046/j.1365-2133.2000.03665.x
Increased circulating skin‐homing cutaneous lymphocyte‐associated antigen (CLA)+ type 2 cytokine‐producing cells, and decreased CLA+ type 1 cytokine‐producing cells in atopic dermatitis
Y. Teraki (2000)
10.1084/JEM.191.6.995
Signal Transducer and Activator of Transcription 6 Is Essential in the Induction of Contact Hypersensitivity
H. Yokozeki (2000)
10.1067/MAI.2001.112601
CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis.
T. Nakatani (2001)
10.1046/J.0022-202X.2001.01484.X
Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis.
L. S. Chan (2001)
10.1093/NAR/29.9.E45
A new mathematical model for relative quantification in real-time RT-PCR.
M. Pfaffl (2001)
10.1074/jbc.M201140200
A Novel Type I Cytokine Receptor Is Expressed on Monocytes, Signals Proliferation, and Activates STAT-3 and STAT-5*
N. Ghilardi (2002)
10.4049/jimmunol.168.4.2020
Development of Atopic Dermatitis-Like Skin Lesions in STAT6-Deficient NC/Nga Mice1
Ryouji Yagi (2002)
10.1074/jbc.M307286200
GPL, a Novel Cytokine Receptor Related to GP130 and Leukemia Inhibitory Factor Receptor*
Caroline Diveu (2003)
10.1111/j.1365-2133.2003.05750.x
Methylisothiazolinones elicit increased production of both T helper (Th)1‐ and Th2‐like cytokines by peripheral blood mononuclear cells from contact allergic individuals
K. Masjedi (2003)
10.1016/J.JACI.2003.09.032
Immune mechanisms leading to atopic dermatitis.
N. Novak (2003)
10.1038/ni1084
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
S. Dillon (2004)
10.1038/sj.gt.3302341
In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model
H. Yokozeki (2004)
CLA(+) T cells in cutaneous diseases.
L. Santamaria-Babí (2004)
10.1038/sj.gt.3302345
In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity
K. Sumi (2004)
The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis.
P. Saint-Mézard (2004)
10.1016/J.IT.2004.03.006
Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression.
W. Lew (2004)
10.1016/J.IMMUNI.2005.05.008
Probabilistic regulation in TH2 cells accounts for monoallelic expression of IL-4 and IL-13.
L. Guo (2005)
10.1016/J.EJPHAR.2005.04.040
Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis.
A. Takaoka (2005)
10.1016/J.JACI.2005.10.046
IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.
J. Bilsborough (2006)
10.1016/J.JACI.2005.10.033
IL-31: a new link between T cells and pruritus in atopic skin inflammation.
Enikő Sonkoly (2006)
10.1111/j.1600-0625.2006.00405.x
Involvement of IL‐31 on scratching behavior in NC/Nga mice with atopic‐like dermatitis
A. Takaoka (2006)



This paper is referenced by
10.3390/biomedicines9030229
Intractable Itch in Atopic Dermatitis: Causes and Treatments
Y. Umehara (2021)
10.21608/bjas.2021.189504
Serum IL-13 Level in Pregnancy Related Pruritus
O.H. Al Kady (2021)
10.3390/cells10061392
Current Insights into Immunology and Novel Therapeutics of Atopic Dermatitis
H. Kader (2021)
10.1016/j.iac.2021.04.001
Advances in the Translational Science of Dermatitis.
S. Bilimoria (2021)
10.1007/s40265-021-01521-1
IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses
Y. S. Roh (2021)
10.1155/2021/5582581
IL-31 and IL-8 in Cutaneous T-Cell Lymphoma: Looking for Their Role in Itch
M. Abreu (2021)
10.1186/s40824-021-00224-8
Overcome the barriers of the skin: exosome therapy
Gi Hoon Yang (2021)
10.1007/s00109-021-02058-2
DUOX1 in mammalian disease pathophysiology.
N. Ashtiwi (2021)
10.3389/fmed.2021.639097
Interleukin-31 Signaling Bridges the Gap Between Immune Cells, the Nervous System and Epithelial Tissues
J. Nemmer (2021)
10.3390/nu13072448
Immunomodulatory and Anti-inflammatory Effects of Asiatic Acid in a DNCB-Induced Atopic Dermatitis Animal Model
Gyoo Moon (2021)
10.3389/fimmu.2021.696784
Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis
J. Meng (2021)
10.1080/1744666X.2021.1940962
The IL-4, IL-13 and IL-31 pathways in atopic dermatitis
C. Dubin (2021)
10.1016/j.jaci.2021.01.013
Biomarkers in atopic dermatitis - a review on behalf of the international eczema council.
Y. Renert-Yuval (2021)
10.3889/oamjms.2021.5599
Interleukin-31 Serum And Pruritus Dimension After Acupuncture Treatment In Hemodialysis Patients: A Randomized Clinical Trial
D. Ardinata (2021)
10.3389/fmed.2021.638325
Interleukin-31 as a Clinical Target for Pruritus Treatment
K. Kabashima (2021)
10.3390/pharmaceutics13071044
Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
Paul Smith (2021)
10.1080/08820139.2020.1785490
Implication of Increased Serum IL-31 for Primary Biliary Cholangitis
Ning Mu (2020)
10.1016/j.heliyon.2020.e05621
Increased serum IL-31 levels in chronic spontaneous urticaria and psoriasis with pruritic symptoms
S. Chaowattanapanit (2020)
10.1038/s41598-020-65502-2
Caffeoyl–Pro–His amide relieve DNCB-Induced Atopic Dermatitis-Like phenotypes in BALB/c mice
Sunhyae Jang (2020)
10.3389/fphar.2020.01019
Ameliorative and Synergic Effects of Derma-H, a New Herbal Formula, on Allergic Contact Dermatitis
S. Jo (2020)
10.1016/j.jtcms.2020.10.006
Shizhenqing granule stimulates the hypothalamic-pituitary-adrenal axis and reduces serum pro-inflammatory factors in a rat model with chronic eczema
Jinrui Lu (2020)
10.1016/j.jid.2020.02.008
SnapshotDx Quiz: April 2020.
J. McBride (2020)
10.1016/j.jisp.2020.04.008
A Potential Role for IL-4 and IL-13 in an Alopecia Areata-Like Phenotype: A Clinical Perspective.
D. Marks (2020)
10.29245/2689-9981/2020/1.1155
The Fascination of Cytokine Immunological Science
P. Lissoni (2020)
10.1021/acs.biochem.0c00176
Feline Interleukin-31 shares overlapping epitopes with Oncostatin M Receptor and IL-31RA.
Angélica V. Medina-Cucurella (2020)
10.1016/j.immuni.2020.04.008
Itch: A Paradigm of Neuroimmune Crosstalk.
F. Wang (2020)
10.20463/pan.2020.0022
Anti-atopic dermatitis properties of Cordyceps militaris on TNFα/IFNγ-stimulated HaCaT cells and experimentally induced atopic dermatitis in mice
E. Choi (2020)
10.7150/ijms.45765
Rapamycin blocks the IL-13-induced deficiency of Epidermal Barrier Related Proteins via upregulation of miR-143 in HaCaT Keratinocytes
Q. Jia (2020)
10.1007/s40257-020-00534-y
Emerging Therapeutic Options for Chronic Pruritus
R. Reszke (2020)
10.1071/an19500
Sika deer (Cervus nippon) velvet antler ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like clinical signs in a rodent model
Youngjin Choi (2020)
10.1016/j.jaad.2019.12.015
Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study.
H. Nakagawa (2020)
10.2147/CCID.S257647
IL-33/13 Axis and IL-4/31 Axis Play Distinct Roles in Inflammatory Process and Itch in Psoriasis and Atopic Dermatitis
K. Bodoor (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar